Addressing the Role of Consolidation Immunotherapy in Patients With Lung Cancer
February 4th 2020Nasser H. Hanna, MD, discusses the key takeaways on the current role of consolidation immunotherapy in patients with lung cancer, which has become standard in this setting. He highlights questions that still need to be addressed in this space.